The Compliance Corner: The Designated Person—To Be or Not To Be?
VP of Business Development Michelle Woosley, PharmD., MBA, CM&AP, FACA shares best practice tips on the Designated Person role under USP Chapters <795>, <797>, and <800>.
Updates and announcements from GHA Consulting.
VP of Business Development Michelle Woosley, PharmD., MBA, CM&AP, FACA shares best practice tips on the Designated Person role under USP Chapters <795>, <797>, and <800>.
Gates Healthcare Associates unveils a redesigned website that reflects its expanding role as a national compliance partner for 503A and 503B pharmacies, with improved service clarity and a modernized digital experience.